News

Verseau Therapeutics, Inc. launched with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration's (FDA) approval of STELARA® (ustekinumab) for the treatment of adult…
Read More...

Biogen Inc. and Samsung Bioepis announced that they will present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes FLIXABI (infliximab) and IMRALDI…
Read More...

Alexion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved ULTOMIRIS (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a…
Read More...

Thermo Fisher Scientific, the world leader in serving science, announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel.…
Read More...

Horizon Therapeutics plc announced it has initiated an open-label clinical trial evaluating the use of KRYSTEXXA (pegloticase injection) in adults with chronic gout refractory to…
Read More...

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA)…
Read More...

ArsenalBio makes its debut today backed by $85 million Series A financing to build a programmable cell therapy company to create highly effective and accessible immune cell therapies.…
Read More...

Teijin Limited (Teijin) and NeuroSigma, Inc. (NeuroSigma), a Los Angeles-based bioelectronics company focused on developing Trigeminal Nerve Stimulation (TNS) technology for the…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced the submission of a supplemental New Drug…
Read More...

Mesoblast and Lonza announced that they have entered into an agreement for commercial manufacture of Mesoblast’s lead allogeneic (off-the-shelf) cell therapy product candidate,…
Read More...

HitGen Inc. announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against targets of interest to…
Read More...

Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has launched Drizalma Sprinkle (duloxetine delayed-release capsules) in the U.S. for oral use.…
Read More...

TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utilizing the latest isolator…
Read More...

Alexion Pharmaceuticals and Achillion Pharmaceuticals announced that they have entered into a definitive agreement for Alexion to acquire Achillion, a clinical-stage biopharmaceutical…
Read More...

GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta (γδ) T-cells to develop transformational immunotherapies, announced the formation of a…
Read More...

Trialbee, a world-leading technology provider in patient matching and engagement, is partnering with TriNetX, a leading global real-world health research network comprised of >170M…
Read More...

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and KSQ Therapeutics, a biotechnology company using CRISPR…
Read More...

Sanofi celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital facilities using intensified,…
Read More...